Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1992-8-13
|
pubmed:abstractText |
In the human Ewing's sarcoma cell line WE-68, saturation analysis using 3H-labelled neuropeptide Y ([3H]NPY) as the radioligand disclosed a homogeneous population of binding sites with a dissociation constant (Kd) of 4.5 nM and maximal binding capacity (B(max)) of 712 fmol/mg cell protein. Besides the WE-68 cell line, ten other human Ewing's sarcoma cell lines (FM-62, HS-80, HT-78, HT-M1-78, NT-68, RM-82, RS-63, VH-64, WE-M1-68, WE-M2-68) were also found to display NPY receptors with Kd varying from 3.5 nM to 10.7 nM and B(max) = 247-3744 fmol/mg cell protein. NPY, its natural analogues and the Y1-receptor-specific peptide ligand [Leu31,Pro34]NPY inhibited [3H]NPY binding in the potency order: [Leu31,Pro34]NPY greater than or equal to human NPY greater than or equal to peptide YY (PYY) greater than salmon pancreatic polypeptide (PP) greater than human PP greater than porcine NPY13-36 much greater than NPY22-36. In the Ewing's sarcoma cell lines NPY provoked inhibition of forskolin-stimulated cyclic AMP formation by up to 98%. Pertussis toxin alleviated the cyclic-AMP-inhibitory response to NPY. In isolated Ewing's sarcoma plasma membranes pertussis toxin [32P]ADP-ribosylated a 41-kDa protein. The ability of NPY and analogues to inhibit cyclic AMP accumulation paralleled their potencies in displacing radioligand binding. By contrast, a cell line derived from an atypical form of Ewing's sarcoma did not express specific and functional NPY receptors. These results demonstrate that conventional Ewing's sarcoma cells possess Gi-protein-coupled NPY receptors of the Y1 type, which upon interaction with NPY, PYY, and PP mediate inhibition of cyclic AMP generation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptide Y,
http://linkedlifedata.com/resource/pubmed/chemical/Pancreatic Polypeptide,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neuropeptide Y,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neurotransmitter
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0171-5216
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
118
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
529-36
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1320624-Adult,
pubmed-meshheading:1320624-Binding, Competitive,
pubmed-meshheading:1320624-Child,
pubmed-meshheading:1320624-Cyclic AMP,
pubmed-meshheading:1320624-Female,
pubmed-meshheading:1320624-Humans,
pubmed-meshheading:1320624-Male,
pubmed-meshheading:1320624-Neuropeptide Y,
pubmed-meshheading:1320624-Pancreatic Polypeptide,
pubmed-meshheading:1320624-Radioligand Assay,
pubmed-meshheading:1320624-Receptors, Neuropeptide Y,
pubmed-meshheading:1320624-Receptors, Neurotransmitter,
pubmed-meshheading:1320624-Sarcoma, Ewing,
pubmed-meshheading:1320624-Tumor Cells, Cultured
|
pubmed:year |
1992
|
pubmed:articleTitle |
Expression of functional Y1 receptors for neuropeptide Y in human Ewing's sarcoma cell lines.
|
pubmed:affiliation |
Abt. für Pädiatrische Hämatologie und Onkologie, Westfälische Wilhelms-Universität, Münster, Federal Republic of Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|